Literature DB >> 24246388

TLRs and interferons: a central paradigm in autoimmunity.

Dwight H Kono1, Roberto Baccala, Argyrios N Theofilopoulos.   

Abstract

Investigations into the pathogenesis of lupus have largely focused on abnormalities in components of the adaptive immune system. Despite important advances, however, the question about the origin of the pathogenic process, the primary disease trigger, and the dominance of autoantibodies against nuclear components, remained unanswered. Discoveries in the last decade have provided some resolution to these questions by elucidating the central role of nucleic acid-sensing TLRs and the attendant inflammatory response, particularly the production of type I interferons. These priming events are responsible for initiating the adaptive responses that ultimately mediate the pathogenic process.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24246388      PMCID: PMC4309276          DOI: 10.1016/j.coi.2013.10.006

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  80 in total

1.  Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice.

Authors:  Déborah Braun; Pedro Geraldes; Jocelyne Demengeot
Journal:  J Autoimmun       Date:  2003-02       Impact factor: 7.094

2.  Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.

Authors:  Amanda L Gavin; Kasper Hoebe; Bao Duong; Takayuki Ota; Christopher Martin; Bruce Beutler; David Nemazee
Journal:  Science       Date:  2006-12-22       Impact factor: 47.728

3.  Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages.

Authors:  Kohki Kawane; Mayumi Ohtani; Keiko Miwa; Takuji Kizawa; Yoshiyuki Kanbara; Yoshichika Yoshioka; Hideki Yoshikawa; Shigekazu Nagata
Journal:  Nature       Date:  2006-10-26       Impact factor: 49.962

4.  FcγRIIB regulation of BCR/TLR-dependent autoreactive B-cell responses.

Authors:  Ana M Avalos; Melissa B Uccellini; Petar Lenert; Gregory A Viglianti; Ann Marshak-Rothstein
Journal:  Eur J Immunol       Date:  2010-10       Impact factor: 5.532

5.  Role of nucleic acid-sensing TLRs in diverse autoantibody specificities and anti-nuclear antibody-producing B cells.

Authors:  Yi Ting Koh; John C Scatizzi; Jennifer D Gahan; Brian R Lawson; Roberto Baccala; K Michael Pollard; Bruce A Beutler; Argyrios N Theofilopoulos; Dwight H Kono
Journal:  J Immunol       Date:  2013-04-15       Impact factor: 5.422

Review 6.  Fueling autoimmunity: type I interferon in autoimmune diseases.

Authors:  Jeremy Di Domizio; Wei Cao
Journal:  Expert Rev Clin Immunol       Date:  2013-03       Impact factor: 4.473

Review 7.  The genetics of type I interferon in systemic lupus erythematosus.

Authors:  Paola G Bronson; Christina Chaivorapol; Ward Ortmann; Timothy W Behrens; Robert R Graham
Journal:  Curr Opin Immunol       Date:  2012-08-10       Impact factor: 7.486

8.  Trex1 prevents cell-intrinsic initiation of autoimmunity.

Authors:  Daniel B Stetson; Joan S Ko; Thierry Heidmann; Ruslan Medzhitov
Journal:  Cell       Date:  2008-08-22       Impact factor: 41.582

9.  Clinical and molecular phenotype of Aicardi-Goutieres syndrome.

Authors:  Gillian Rice; Teresa Patrick; Rekha Parmar; Claire F Taylor; Alec Aeby; Jean Aicardi; Rafael Artuch; Simon Attard Montalto; Carlos A Bacino; Bruno Barroso; Peter Baxter; Willam S Benko; Carsten Bergmann; Enrico Bertini; Roberta Biancheri; Edward M Blair; Nenad Blau; David T Bonthron; Tracy Briggs; Louise A Brueton; Han G Brunner; Christopher J Burke; Ian M Carr; Daniel R Carvalho; Kate E Chandler; Hans-Jurgen Christen; Peter C Corry; Frances M Cowan; Helen Cox; Stefano D'Arrigo; John Dean; Corinne De Laet; Claudine De Praeter; Catherine Dery; Colin D Ferrie; Kim Flintoff; Suzanna G M Frints; Angels Garcia-Cazorla; Blanca Gener; Cyril Goizet; Francoise Goutieres; Andrew J Green; Agnes Guet; Ben C J Hamel; Bruce E Hayward; Arvid Heiberg; Raoul C Hennekam; Marie Husson; Andrew P Jackson; Rasieka Jayatunga; Yong-Hui Jiang; Sarina G Kant; Amy Kao; Mary D King; Helen M Kingston; Joerg Klepper; Marjo S van der Knaap; Andrew J Kornberg; Dieter Kotzot; Wilfried Kratzer; Didier Lacombe; Lieven Lagae; Pierre Georges Landrieu; Giovanni Lanzi; Andrea Leitch; Ming J Lim; John H Livingston; Charles M Lourenco; E G Hermione Lyall; Sally A Lynch; Michael J Lyons; Daphna Marom; John P McClure; Robert McWilliam; Serge B Melancon; Leena D Mewasingh; Marie-Laure Moutard; Ken K Nischal; John R Ostergaard; Julie Prendiville; Magnhild Rasmussen; R Curtis Rogers; Dominique Roland; Elisabeth M Rosser; Kevin Rostasy; Agathe Roubertie; Amparo Sanchis; Raphael Schiffmann; Sabine Scholl-Burgi; Sunita Seal; Stavit A Shalev; C Sierra Corcoles; Gyan P Sinha; Doriette Soler; Ronen Spiegel; John B P Stephenson; Uta Tacke; Tiong Yang Tan; Marianne Till; John L Tolmie; Pam Tomlin; Federica Vagnarelli; Enza Maria Valente; Rudy N A Van Coster; Nathalie Van der Aa; Adeline Vanderver; Johannes S H Vles; Thomas Voit; Evangeline Wassmer; Bernhard Weschke; Margo L Whiteford; Michel A A Willemsen; Andreas Zankl; Sameer M Zuberi; Simona Orcesi; Elisa Fazzi; Pierre Lebon; Yanick J Crow
Journal:  Am J Hum Genet       Date:  2007-09-04       Impact factor: 11.025

10.  Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study.

Authors:  Michelle Petri; Daniel J Wallace; Alberto Spindler; Vishala Chindalore; Kenneth Kalunian; Eduardo Mysler; C Michael Neuwelt; Gabriel Robbie; Wendy I White; Brandon W Higgs; Yihong Yao; Liangwei Wang; Dominique Ethgen; Warren Greth
Journal:  Arthritis Rheum       Date:  2013-04
View more
  23 in total

Review 1.  PD-1 immunobiology in systemic lupus erythematosus.

Authors:  Colleen S Curran; Sarthak Gupta; Ignacio Sanz; Elad Sharon
Journal:  J Autoimmun       Date:  2018-11-03       Impact factor: 7.094

Review 2.  Type I interferon in the pathogenesis of lupus.

Authors:  Mary K Crow
Journal:  J Immunol       Date:  2014-06-15       Impact factor: 5.422

Review 3.  Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.

Authors:  Vaishali R Moulton; Abel Suarez-Fueyo; Esra Meidan; Hao Li; Masayuki Mizui; George C Tsokos
Journal:  Trends Mol Med       Date:  2017-06-13       Impact factor: 11.951

4.  Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN.

Authors:  K Michael Pollard; Gabriela M Escalante; Hua Huang; Katarina M Haraldsson; Per Hultman; Joseph M Christy; Rahul D Pawar; Jessica M Mayeux; Rosana Gonzalez-Quintial; Roberto Baccala; Bruce Beutler; Argyrios N Theofilopoulos; Dwight H Kono
Journal:  J Immunol       Date:  2017-10-20       Impact factor: 5.422

5.  Environmental Xenobiotic Exposure and Autoimmunity.

Authors:  K Michael Pollard; Joseph M Christy; David M Cauvi; Dwight H Kono
Journal:  Curr Opin Toxicol       Date:  2017-11-21

6.  The effect of the autoimmunity-associated gene, PTPN22, on a BXSB-derived model of lupus.

Authors:  Christian J Maine; Kristi Marquardt; John C Scatizzi; K Michael Pollard; Dwight H Kono; Linda A Sherman
Journal:  Clin Immunol       Date:  2014-11-11       Impact factor: 3.969

7.  Neutrophils Regulate Humoral Autoimmunity by Restricting Interferon-γ Production via the Generation of Reactive Oxygen Species.

Authors:  Xinfang Huang; Jingjing Li; Stephanie Dorta-Estremera; Jeremy Di Domizio; Scott M Anthony; Stephanie S Watowich; Daniel Popkin; Zheng Liu; Philip Brohawn; Yihong Yao; Kimberly S Schluns; Lewis L Lanier; Wei Cao
Journal:  Cell Rep       Date:  2015-08-06       Impact factor: 9.423

8.  B Cell αv Integrins Regulate TLR-Driven Autoimmunity.

Authors:  Mridu Acharya; Fiona Raso; Sara Sagadiev; Emily Gilbertson; Lauren Kadavy; Quan Z Li; Mei Yan; Lynda M Stuart; Jessica A Hamerman; Adam Lacy-Hulbert
Journal:  J Immunol       Date:  2020-08-28       Impact factor: 5.422

Review 9.  Advances in understanding the role of type I interferons in systemic lupus erythematosus.

Authors:  Mary K Crow
Journal:  Curr Opin Rheumatol       Date:  2014-09       Impact factor: 5.006

Review 10.  Type I interferon in the pathogenesis of systemic lupus erythematosus.

Authors:  Mariana Postal; Jessica F Vivaldo; Ruth Fernandez-Ruiz; Jacqueline L Paredes; Simone Appenzeller; Timothy B Niewold
Journal:  Curr Opin Immunol       Date:  2020-11-24       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.